1. Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide. (13th November 2013) Authors: Neuner, Philippe; Peier, Andrea M.; Talamo, Fabio; Ingallinella, Paolo; Lahm, Armin; Barbato, Gaetano; Di Marco, Annalise; Desai, Kunal; Zytko, Karolina; Qian, Ying; Du, Xiaobing; Ricci, Davide; Monteagudo, Edith; Laufer, Ralph; Pocai, Alessandro; Bianchi, Elisabetta; Marsh, Donald J.; Pessi, Ant... Journal: Journal of peptide science Issue: Volume 20:Number 1(2014:Jan.) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Issue 23 (15th December 2018) Authors: Ferrigno, Federica; Biancofiore, Ilaria; Malancona, Savina; Ponzi, Simona; Paonessa, Giacomo; Graziani, Rita; Bresciani, Alberto; Gennari, Nadia; Di Marco, Annalise; Kaiser, Marcel; Summa, Vincenzo; Harper, Steven; Ontoria, Jesus M. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 28:Issue 23/24(2018) Page Start: 3689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗